{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-027827","form_type":"8-K","ticker":null,"cik":"0001642375","company_name":"Guardion Health Sciences, Inc.","filed_at":"2024-07-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.922790+00:00","generated_at":"2026-05-31T20:42:41.970587+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Guardion Health Sciences CCO Craig Sheehan departs; receives $148k separation plus $35k bonus","bullets":["Craig Sheehan terminated as Chief Commercial Officer effective July 10, 2024.","Separation payment of approximately $148,000 plus a $35,000 retention bonus.","Sheehan managed the Viactiv brand, which was sold to Doctor's Best on May 31, 2024.","Resigned all officer/director positions including at subsidiaries."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-027827","json":"https://secwatch.observer/filing/0001493152-24-027827.json","markdown":"https://secwatch.observer/filing/0001493152-24-027827.md","text":"https://secwatch.observer/filing/0001493152-24-027827.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642375/000149315224027827/0001493152-24-027827-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642375/000149315224027827/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T20:42:41.970587+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bbd757009e","claim":"Craig Sheehan was terminated as Chief Commercial Officer at Guardion Health Sciences, Inc..","evidence_excerpt":"On July 10, 2024 (the “Separation Date”), Guardion Health Sciences, Inc. (the “Company”) entered into a Separation Agreement and General Release (the “Separation Agreement”) with Craig Sheehan, its Chief Commercial Officer, whereby the Company and Mr. Sheehan mutually agreed to terminate Mr. Sheehan’s employment with the Company as of the Separation Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1642375/000149315224027827/0001493152-24-027827-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Chief Commercial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}